Protocol Citation: Nathan Wright 2025. Setup and Operation of Single Use (SUB) Bubble Column Reactors (BCR) for Recombinant Proteins: Litre-Scale Expression of enterovirus 3C protease for Structural Biology and Drug Design (SBDD). protocols.io https://dx.doi.org/10.17504/protocols.io.36wgqp4ykvk5/v1 License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Protocol status: WorkingWe use this protocol and it's working
Created: July 25, 2025
Last Modified: July 29, 2025
Protocol Integer ID: 223266
Keywords: Single-Use, Bubble Column Reactor, protein production, SBDD, crystallising disease target protein, based drug discovery, protein crystallography, flask workflows for protein expression, drug discovery, approach to drug design, drug design, medicines discovery, multiple protein, centre for medicines discovery, molecule binder, disease target protein, protein quantity, structural biology, scale expression of recombinant protein, column bioreactor, protein expression, bioreactor array, high demand for protein quantity, obtaining sufficient protein quantity, increasing protein production efficiency, protein production efficiency, crystal form, recombinant protein, crystallisation, sufficient protein quantity, crystallisation behaviour, E. coli, EV-D68, EV-A71, 3C protease, scale expression of enterovirus 3c protease, enterovirus 3c protease, recombinant expression of enterovirus 3c protease, parallel processing of multiple 3c protease variant, multiple 3c protease variant, using magnetic bead purification, a71 3c protease, 3c protease, use bubble
Funders Acknowledgements:National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
Grant ID: U19AI171399